Automatic Biopsy Systems Comprehensive Study by Type (Aspiration Biopsy Needles, Vacuum-assisted Biopsy System, Localization Wires, Procedure Trays, Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), End-User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centres), Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others) Players and Region - Global Market Outlook to 2028

Automatic Biopsy Systems Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Automatic Biopsy Systems Market Scope?
Biopsy has been one of the most important diagnosis techniques for cancer disorders and is widely used in the designation of breast, skin, and prostate cancer. With the increasing incidence of cancer cases and developments in biopsy systems, the market is anticipated to extend. There's additionally a requirement for minimally invasive biopsy procedures that are rising at a big rate within the market. The various styles of technologies and products, like biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices are anticipated to witness high growth throughout the forecast amount. Additionally, the growing awareness relating to breast cancer treatment and designation can support the rise within the diagnostic assay devices market size in the future years. There are several countries that hold programs for the first designation of breast cancer. Therefore, such initiatives can accelerate the adoption rate of automatic biopsy systems, thereby completely impacting the expansion of the Automatic Biopsy Systems.

Influencing Trend:
Increasing Adoption of The System and High Recommendation from The Doctors

Market Growth Drivers:
Increasing Preference for Minimally Invasive Procedures and Increase in The Number of Cancer Cases Worldwide

Challenges:
Presence of Competitors and Lack of Skilled Professionals

Restraints:
High Cost of The System

Opportunities:
Initiatives Undertaken by Government for Diagnosis

The Automatic Biopsy Systems market study is being classified by Type (Aspiration Biopsy Needles, Vacuum-assisted Biopsy System, Localization Wires, Procedure Trays and Others), by Application and major geographies with country level break-up.

The market is increasing due to the increasing application and the demand from the hospitals. The growth in this market is primarily attributed to the rising prevalence of cancer, increasing demand for minimally invasive surgeries, initiatives undertaken by government & global health organizations to spread awareness about cancer, and the improved reimbursement scenario. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Automatic Biopsy Systems market throughout the predicted period.

C. R. Bard, Inc. (United States), Becton, Dickinson and Company (United States), Cook Group Incorporated (United States), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (United States), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (United States), Olympus Corporation (Japan), Boston Scientific Corporation (United States), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (United States) and Medtronic plc (Ireland) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Automatic Biopsy Systems market by Type, Application and Region.

On the basis of geography, the market of Automatic Biopsy Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In February 2019, IZI Medical Products LLC, an interventional radiology medical device company and portfolio company of Shore Capital Partners LLC, acquired select soft tissue biopsy and breast localization needle assets from Cook Medical. The acquired product portfolio is marketed as the Quick-Core Biopsy Needle, MReye Breast Localization Coil, Kopans, and X-Reidy Lesion Localization Needle.
In September 2019, B. Braun Melsungen AG, a global leader in health technology and global leader in local anesthesia and pain management, launched Onvision, a groundbreaking ultrasound guidance solution for real-time needle tip tracking under local anesthesia. Available on the latest versions of the B. Braun and Philips Xperius ultrasound systems, Onvision gives anesthesiologists the confidence to accurately position the needle tip inside the body. This introduction is part of a multi-year strategic partnership between Philips and B. Braun to revolutionize ultrasound-guided local anesthesia, a rapidly growing alternative to general anesthesia.


Key Target Audience
Manufacturers of Automatic Biopsy Systems, Suppliers and distributors of Automatic Biopsy Systems, Governmental and Regulatory bodies, End-Users and Potential Investors

Automatic Biopsy Systems Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Automatic Biopsy Systems Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Automatic Biopsy Systems industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Aspiration Biopsy Needles
  • Vacuum-assisted Biopsy System
  • Localization Wires
  • Procedure Trays
  • Others
By Application
  • Breast Biopsy
  • Lung Biopsy
  • Colorectal Biopsy
  • Prostate Biopsy
  • Others
By End-User
  • Hospitals
  • Academic and Research Institutes
  • Diagnostic and Imaging Centres

By Technique
  • Ultrasound-Guided Biopsy
  • Stereotactic-Guided Biopsy
  • MRI-Guided Biopsy
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Preference for Minimally Invasive Procedures
      • 3.2.2. Increase in The Number of Cancer Cases Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Presence of Competitors
      • 3.3.2. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption of The System
      • 3.4.2. High Recommendation from The Doctors
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Automatic Biopsy Systems, by Type, Application, End-User, Technique and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Automatic Biopsy Systems (Value)
      • 5.2.1. Global Automatic Biopsy Systems by: Type (Value)
        • 5.2.1.1. Aspiration Biopsy Needles
        • 5.2.1.2. Vacuum-assisted Biopsy System
        • 5.2.1.3. Localization Wires
        • 5.2.1.4. Procedure Trays
        • 5.2.1.5. Others
      • 5.2.2. Global Automatic Biopsy Systems by: Application (Value)
        • 5.2.2.1. Breast Biopsy
        • 5.2.2.2. Lung Biopsy
        • 5.2.2.3. Colorectal Biopsy
        • 5.2.2.4. Prostate Biopsy
        • 5.2.2.5. Others
      • 5.2.3. Global Automatic Biopsy Systems by: End-User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Academic and Research Institutes
        • 5.2.3.3. Diagnostic and Imaging Centres
      • 5.2.4. Global Automatic Biopsy Systems by: Technique (Value)
        • 5.2.4.1. Ultrasound-Guided Biopsy
        • 5.2.4.2. Stereotactic-Guided Biopsy
        • 5.2.4.3. MRI-Guided Biopsy
        • 5.2.4.4. Others
      • 5.2.5. Global Automatic Biopsy Systems Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Automatic Biopsy Systems (Price)
      • 5.3.1. Global Automatic Biopsy Systems by: Type (Price)
  • 6. Automatic Biopsy Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. C. R. Bard, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cook Group Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Argon Medical Devices (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. B. Braun Melsungen AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cardinal Health, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Olympus Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Boston Scientific Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. FUJIFILM Holdings Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. INRAD, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Medtronic plc (Ireland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Automatic Biopsy Systems Sale, by Type, Application, End-User, Technique and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Automatic Biopsy Systems (Value)
      • 7.2.1. Global Automatic Biopsy Systems by: Type (Value)
        • 7.2.1.1. Aspiration Biopsy Needles
        • 7.2.1.2. Vacuum-assisted Biopsy System
        • 7.2.1.3. Localization Wires
        • 7.2.1.4. Procedure Trays
        • 7.2.1.5. Others
      • 7.2.2. Global Automatic Biopsy Systems by: Application (Value)
        • 7.2.2.1. Breast Biopsy
        • 7.2.2.2. Lung Biopsy
        • 7.2.2.3. Colorectal Biopsy
        • 7.2.2.4. Prostate Biopsy
        • 7.2.2.5. Others
      • 7.2.3. Global Automatic Biopsy Systems by: End-User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Academic and Research Institutes
        • 7.2.3.3. Diagnostic and Imaging Centres
      • 7.2.4. Global Automatic Biopsy Systems by: Technique (Value)
        • 7.2.4.1. Ultrasound-Guided Biopsy
        • 7.2.4.2. Stereotactic-Guided Biopsy
        • 7.2.4.3. MRI-Guided Biopsy
        • 7.2.4.4. Others
      • 7.2.5. Global Automatic Biopsy Systems Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Automatic Biopsy Systems (Price)
      • 7.3.1. Global Automatic Biopsy Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Automatic Biopsy Systems: by Type(USD Million)
  • Table 2. Automatic Biopsy Systems Aspiration Biopsy Needles , by Region USD Million (2017-2022)
  • Table 3. Automatic Biopsy Systems Vacuum-assisted Biopsy System , by Region USD Million (2017-2022)
  • Table 4. Automatic Biopsy Systems Localization Wires , by Region USD Million (2017-2022)
  • Table 5. Automatic Biopsy Systems Procedure Trays , by Region USD Million (2017-2022)
  • Table 6. Automatic Biopsy Systems Others , by Region USD Million (2017-2022)
  • Table 7. Automatic Biopsy Systems: by Application(USD Million)
  • Table 8. Automatic Biopsy Systems Breast Biopsy , by Region USD Million (2017-2022)
  • Table 9. Automatic Biopsy Systems Lung Biopsy , by Region USD Million (2017-2022)
  • Table 10. Automatic Biopsy Systems Colorectal Biopsy , by Region USD Million (2017-2022)
  • Table 11. Automatic Biopsy Systems Prostate Biopsy , by Region USD Million (2017-2022)
  • Table 12. Automatic Biopsy Systems Others , by Region USD Million (2017-2022)
  • Table 13. Automatic Biopsy Systems: by End-User(USD Million)
  • Table 14. Automatic Biopsy Systems Hospitals , by Region USD Million (2017-2022)
  • Table 15. Automatic Biopsy Systems Academic and Research Institutes , by Region USD Million (2017-2022)
  • Table 16. Automatic Biopsy Systems Diagnostic and Imaging Centres , by Region USD Million (2017-2022)
  • Table 17. Automatic Biopsy Systems: by Technique(USD Million)
  • Table 18. Automatic Biopsy Systems Ultrasound-Guided Biopsy , by Region USD Million (2017-2022)
  • Table 19. Automatic Biopsy Systems Stereotactic-Guided Biopsy , by Region USD Million (2017-2022)
  • Table 20. Automatic Biopsy Systems MRI-Guided Biopsy , by Region USD Million (2017-2022)
  • Table 21. Automatic Biopsy Systems Others , by Region USD Million (2017-2022)
  • Table 22. South America Automatic Biopsy Systems, by Country USD Million (2017-2022)
  • Table 23. South America Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 24. South America Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 25. South America Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 26. South America Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 27. Brazil Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 28. Brazil Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 29. Brazil Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 30. Brazil Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 31. Argentina Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 32. Argentina Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 33. Argentina Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 34. Argentina Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 35. Rest of South America Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 36. Rest of South America Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 37. Rest of South America Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 38. Rest of South America Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 39. Asia Pacific Automatic Biopsy Systems, by Country USD Million (2017-2022)
  • Table 40. Asia Pacific Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 41. Asia Pacific Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 42. Asia Pacific Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 43. Asia Pacific Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 44. China Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 45. China Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 46. China Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 47. China Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 48. Japan Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 49. Japan Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 50. Japan Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 51. Japan Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 52. India Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 53. India Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 54. India Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 55. India Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 56. South Korea Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 57. South Korea Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 58. South Korea Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 59. South Korea Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 60. Taiwan Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 61. Taiwan Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 62. Taiwan Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 63. Taiwan Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 64. Australia Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 65. Australia Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 66. Australia Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 67. Australia Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 72. Europe Automatic Biopsy Systems, by Country USD Million (2017-2022)
  • Table 73. Europe Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 74. Europe Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 75. Europe Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 76. Europe Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 77. Germany Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 78. Germany Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 79. Germany Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 80. Germany Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 81. France Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 82. France Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 83. France Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 84. France Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 85. Italy Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 86. Italy Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 87. Italy Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 88. Italy Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 89. United Kingdom Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 90. United Kingdom Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 91. United Kingdom Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 92. United Kingdom Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 93. Netherlands Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 94. Netherlands Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 95. Netherlands Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 96. Netherlands Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 97. Rest of Europe Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 98. Rest of Europe Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 99. Rest of Europe Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 100. Rest of Europe Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 101. MEA Automatic Biopsy Systems, by Country USD Million (2017-2022)
  • Table 102. MEA Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 103. MEA Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 104. MEA Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 105. MEA Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 106. Middle East Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 107. Middle East Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 108. Middle East Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 109. Middle East Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 110. Africa Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 111. Africa Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 112. Africa Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 113. Africa Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 114. North America Automatic Biopsy Systems, by Country USD Million (2017-2022)
  • Table 115. North America Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 116. North America Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 117. North America Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 118. North America Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 119. United States Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 120. United States Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 121. United States Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 122. United States Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 123. Canada Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 124. Canada Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 125. Canada Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 126. Canada Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 127. Mexico Automatic Biopsy Systems, by Type USD Million (2017-2022)
  • Table 128. Mexico Automatic Biopsy Systems, by Application USD Million (2017-2022)
  • Table 129. Mexico Automatic Biopsy Systems, by End-User USD Million (2017-2022)
  • Table 130. Mexico Automatic Biopsy Systems, by Technique USD Million (2017-2022)
  • Table 131. Automatic Biopsy Systems: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Automatic Biopsy Systems: by Type(USD Million)
  • Table 145. Automatic Biopsy Systems Aspiration Biopsy Needles , by Region USD Million (2023-2028)
  • Table 146. Automatic Biopsy Systems Vacuum-assisted Biopsy System , by Region USD Million (2023-2028)
  • Table 147. Automatic Biopsy Systems Localization Wires , by Region USD Million (2023-2028)
  • Table 148. Automatic Biopsy Systems Procedure Trays , by Region USD Million (2023-2028)
  • Table 149. Automatic Biopsy Systems Others , by Region USD Million (2023-2028)
  • Table 150. Automatic Biopsy Systems: by Application(USD Million)
  • Table 151. Automatic Biopsy Systems Breast Biopsy , by Region USD Million (2023-2028)
  • Table 152. Automatic Biopsy Systems Lung Biopsy , by Region USD Million (2023-2028)
  • Table 153. Automatic Biopsy Systems Colorectal Biopsy , by Region USD Million (2023-2028)
  • Table 154. Automatic Biopsy Systems Prostate Biopsy , by Region USD Million (2023-2028)
  • Table 155. Automatic Biopsy Systems Others , by Region USD Million (2023-2028)
  • Table 156. Automatic Biopsy Systems: by End-User(USD Million)
  • Table 157. Automatic Biopsy Systems Hospitals , by Region USD Million (2023-2028)
  • Table 158. Automatic Biopsy Systems Academic and Research Institutes , by Region USD Million (2023-2028)
  • Table 159. Automatic Biopsy Systems Diagnostic and Imaging Centres , by Region USD Million (2023-2028)
  • Table 160. Automatic Biopsy Systems: by Technique(USD Million)
  • Table 161. Automatic Biopsy Systems Ultrasound-Guided Biopsy , by Region USD Million (2023-2028)
  • Table 162. Automatic Biopsy Systems Stereotactic-Guided Biopsy , by Region USD Million (2023-2028)
  • Table 163. Automatic Biopsy Systems MRI-Guided Biopsy , by Region USD Million (2023-2028)
  • Table 164. Automatic Biopsy Systems Others , by Region USD Million (2023-2028)
  • Table 165. South America Automatic Biopsy Systems, by Country USD Million (2023-2028)
  • Table 166. South America Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 167. South America Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 168. South America Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 169. South America Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 170. Brazil Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 171. Brazil Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 172. Brazil Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 173. Brazil Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 174. Argentina Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 175. Argentina Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 176. Argentina Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 177. Argentina Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 178. Rest of South America Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 179. Rest of South America Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 180. Rest of South America Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 181. Rest of South America Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 182. Asia Pacific Automatic Biopsy Systems, by Country USD Million (2023-2028)
  • Table 183. Asia Pacific Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 184. Asia Pacific Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 185. Asia Pacific Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 186. Asia Pacific Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 187. China Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 188. China Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 189. China Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 190. China Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 191. Japan Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 192. Japan Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 193. Japan Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 194. Japan Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 195. India Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 196. India Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 197. India Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 198. India Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 199. South Korea Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 200. South Korea Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 201. South Korea Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 202. South Korea Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 203. Taiwan Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 204. Taiwan Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 205. Taiwan Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 206. Taiwan Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 207. Australia Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 208. Australia Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 209. Australia Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 210. Australia Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 211. Rest of Asia-Pacific Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 212. Rest of Asia-Pacific Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 213. Rest of Asia-Pacific Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 214. Rest of Asia-Pacific Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 215. Europe Automatic Biopsy Systems, by Country USD Million (2023-2028)
  • Table 216. Europe Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 217. Europe Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 218. Europe Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 219. Europe Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 220. Germany Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 221. Germany Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 222. Germany Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 223. Germany Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 224. France Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 225. France Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 226. France Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 227. France Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 228. Italy Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 229. Italy Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 230. Italy Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 231. Italy Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 232. United Kingdom Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 233. United Kingdom Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 234. United Kingdom Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 235. United Kingdom Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 236. Netherlands Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 237. Netherlands Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 238. Netherlands Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 239. Netherlands Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 240. Rest of Europe Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 241. Rest of Europe Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 242. Rest of Europe Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 243. Rest of Europe Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 244. MEA Automatic Biopsy Systems, by Country USD Million (2023-2028)
  • Table 245. MEA Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 246. MEA Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 247. MEA Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 248. MEA Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 249. Middle East Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 250. Middle East Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 251. Middle East Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 252. Middle East Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 253. Africa Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 254. Africa Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 255. Africa Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 256. Africa Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 257. North America Automatic Biopsy Systems, by Country USD Million (2023-2028)
  • Table 258. North America Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 259. North America Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 260. North America Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 261. North America Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 262. United States Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 263. United States Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 264. United States Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 265. United States Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 266. Canada Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 267. Canada Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 268. Canada Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 269. Canada Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 270. Mexico Automatic Biopsy Systems, by Type USD Million (2023-2028)
  • Table 271. Mexico Automatic Biopsy Systems, by Application USD Million (2023-2028)
  • Table 272. Mexico Automatic Biopsy Systems, by End-User USD Million (2023-2028)
  • Table 273. Mexico Automatic Biopsy Systems, by Technique USD Million (2023-2028)
  • Table 274. Automatic Biopsy Systems: by Type(USD/Units)
  • Table 275. Research Programs/Design for This Report
  • Table 276. Key Data Information from Secondary Sources
  • Table 277. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Automatic Biopsy Systems: by Type USD Million (2017-2022)
  • Figure 5. Global Automatic Biopsy Systems: by Application USD Million (2017-2022)
  • Figure 6. Global Automatic Biopsy Systems: by End-User USD Million (2017-2022)
  • Figure 7. Global Automatic Biopsy Systems: by Technique USD Million (2017-2022)
  • Figure 8. South America Automatic Biopsy Systems Share (%), by Country
  • Figure 9. Asia Pacific Automatic Biopsy Systems Share (%), by Country
  • Figure 10. Europe Automatic Biopsy Systems Share (%), by Country
  • Figure 11. MEA Automatic Biopsy Systems Share (%), by Country
  • Figure 12. North America Automatic Biopsy Systems Share (%), by Country
  • Figure 13. Global Automatic Biopsy Systems: by Type USD/Units (2017-2022)
  • Figure 14. Global Automatic Biopsy Systems share by Players 2022 (%)
  • Figure 15. Global Automatic Biopsy Systems share by Players (Top 3) 2022(%)
  • Figure 16. Global Automatic Biopsy Systems share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. C. R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. C. R. Bard, Inc. (United States) Revenue: by Geography 2022
  • Figure 20. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 21. Becton, Dickinson and Company (United States) Revenue: by Geography 2022
  • Figure 22. Cook Group Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cook Group Incorporated (United States) Revenue: by Geography 2022
  • Figure 24. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Revenue: by Geography 2022
  • Figure 26. Argon Medical Devices (United States) Revenue, Net Income and Gross profit
  • Figure 27. Argon Medical Devices (United States) Revenue: by Geography 2022
  • Figure 28. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 29. B. Braun Melsungen AG (Germany) Revenue: by Geography 2022
  • Figure 30. Cardinal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cardinal Health, Inc. (United States) Revenue: by Geography 2022
  • Figure 32. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Olympus Corporation (Japan) Revenue: by Geography 2022
  • Figure 34. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 36. FUJIFILM Holdings Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 37. FUJIFILM Holdings Corporation (Japan) Revenue: by Geography 2022
  • Figure 38. INRAD, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. INRAD, Inc. (United States) Revenue: by Geography 2022
  • Figure 40. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 41. Medtronic plc (Ireland) Revenue: by Geography 2022
  • Figure 42. Global Automatic Biopsy Systems: by Type USD Million (2023-2028)
  • Figure 43. Global Automatic Biopsy Systems: by Application USD Million (2023-2028)
  • Figure 44. Global Automatic Biopsy Systems: by End-User USD Million (2023-2028)
  • Figure 45. Global Automatic Biopsy Systems: by Technique USD Million (2023-2028)
  • Figure 46. South America Automatic Biopsy Systems Share (%), by Country
  • Figure 47. Asia Pacific Automatic Biopsy Systems Share (%), by Country
  • Figure 48. Europe Automatic Biopsy Systems Share (%), by Country
  • Figure 49. MEA Automatic Biopsy Systems Share (%), by Country
  • Figure 50. North America Automatic Biopsy Systems Share (%), by Country
  • Figure 51. Global Automatic Biopsy Systems: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • C. R. Bard, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Cook Group Incorporated (United States)
  • Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
  • Argon Medical Devices (United States)
  • B. Braun Melsungen AG (Germany)
  • Cardinal Health, Inc. (United States)
  • Olympus Corporation (Japan)
  • Boston Scientific Corporation (United States)
  • FUJIFILM Holdings Corporation (Japan)
  • INRAD, Inc. (United States)
  • Medtronic plc (Ireland)
Select User Access Type

Key Highlights of Report


May 2023 221 Pages 58 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Automatic Biopsy Systems market are C. R. Bard, Inc. (United States), Becton, Dickinson and Company (United States), Cook Group Incorporated (United States), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (United States), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (United States), Olympus Corporation (Japan), Boston Scientific Corporation (United States), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (United States) and Medtronic plc (Ireland).
In this highly competitive & fast evolving Automatic Biopsy Systems industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Others are the potential customers of Automatic Biopsy Systems industry.

Know More About Global Automatic Biopsy Systems Market Report?